ÅëÇÕ°Ë»ö

Àΰ£À¯¹æ¾Ï¼¼Æ÷ÀÎ MCF-7 ¼¼Æ÷ÁÖ¿¡¼­ Ä«µå¹Å ¹× ºñ¼ÒÀÇ µ¶¼ºÀ¯¹ß ¹× °æ°¨¿¡ °üÇÑ ¿¬±¸

À̹̳­´Ï²¨¾ß > ¹®¼­¹Ú½º > ±âº» Æú´õ | 2008/09/12 ±¸¸Å(0) ¤Ó Á¶È¸(78)
¹®¼­ ¿ä¾àÁ¤º¸
±¸¸ÅÀÚ Æò°¡
  • ÆÇ¸Å°¡°Ý : 4,000¿ø (59Pages)
  • ÀúÀ۽ñâ : 2007/06
  • Ãßõµ¶ÀÚ : ´ëÇпø»ý
¹®¼­ »ó¼¼Á¤º¸
¸®Æ÷Æ® ½ºÅ©¸°  (1/2 screen)
¡Ø ÃÖ´ë 10ÆäÀÌÁö±îÁö ¸®Æ÷Æ® ½ºÅ©¸° À̹ÌÁö¸¦ »ý¼ºÇÕ´Ï´Ù.
¡Ø 5ÆäÀÌÁö ÀÌ»óÀÇ ÀÚ·áÀÎ °æ¿ì À̹ÌÁö¸¦ Ŭ¸¯ÇϽøé 2,4 ÆäÀÌÁö¿¡ ÇØ´çÇÏ´Â Å« À̹ÌÁö¸¦ È®ÀÎÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù
¼Ò°³±Û Àΰ£À¯¹æ¾Ï¼¼Æ÷ÀÎ MCF-7 ¼¼Æ÷ÁÖ¿¡¼­ Ä«µå¹Å ¹× ºñ¼ÒÀÇ µ¶¼ºÀ¯¹ß ¹× °æ°¨¿¡ °üÇÑ ¿¬±¸¸¦ ÇÑ ³í¹®À¸·Î Ä«µå¹Å°ú ºñ¼Ò°¡ Àΰ£À¯¹æ¾Ï¼¼Æ÷¿¡¼­ ¾î¶°ÇÑ µ¶¼ºÀ» ÀÏÀ¸Å°¸ç ¾î¶°ÇÑ ±âÀÛÀ» ÅëÇÏ¿© Àü´ÞµÇ´ÂÁö ºñ±³ºÐ¼®ÇÑ ³»¿ëÀÔ´Ï´Ù.
¸ñÂ÷ I. ¼­·Ð ........................................................1
1.1. Ä«µå¹Å ³ëÃâ ¹× µ¶¼º .......................................5
1.2. ºñ¼Ò ³ëÃâ ¹× µ¶¼º .........................................9
II. ½ÇÇè Àç·á ¹× ¹æ¹ý ..........................................13
2.1. ½ÇÇèÀç·á ¹× ó¸® ..........................................13
2.2. ¼¼Æ÷ÁÖ ¹× ¼¼Æ÷¹è¾ç ........................................13
2.3. ¼¼Æ÷»ç¸ê°ú µ¶¼ºÈ®ÀÎ .......................................14
2.3.1. ¼¼Æ÷ »ýÁ¸À²(MTT assay) ..................................14
2.3.2. Apoptotic bodies °üÂû(DAPI ¿°»ö) ........................15
2.3.3. Apoptotic cell deth °üÂû(DNA fragmentation)..............15
2.3.4. ¼¼Æ÷Áֱ⠰üÂû ¹× ¹ßÇö º¯È­ ..............................16
(1) Flow cytometic analysis(FACS analysis)......................16
(2) ¼¼Æ÷Áֱ⠹ßÇö º¯È­(Cell cycle expression ; Western analysis)17
2.4. ¿¡½ºÆ®·Î°Õ ¼ö¿ëü °æ·Î¸¦ ÅëÇÑ µ¶¼ºÀÇ »ó°ü¼º ¿©ºÎ È®ÀÎ .....18
2.4.1. Á߱ݼÓÀÇ ¿¡½ºÆ®·Î°Õ Ȱ¼º ÃøÁ¤
: ERE-Luc reporter gene assa y..................................18
2.4.2. ¿¡½ºÆ®·Î°Õ ¼ö¿ëü ±æÇ×Á¦ÀÇ Ä«µå¹Å¿¡ ÀÇÇÑ ER Ȱ¼ºÈ­ ÀúÇØ È®ÀÎ19
2.4.3. ¿¡½ºÆ®·Î°Õ ¼ö¿ëü¸¦ ÅëÇÑ µ¶¼º À¯¹ß ±Ô¸í
: ER¥á(-) ¼¼Æ÷(MDA-MB-231)¿¡ ER¥á À¯ÀüÀÚ ÁÖÀÔ...................20
2.4.4. Áß±Ý¼Ó µ¶¼ºÀ¯¹ßÀÌ ´Ü¹éÁú ¹ßÇö¿¡ ¹ÌÄ¡´Â ¿µÇâ..............21
2.4.5. Áß±Ý¼Ó µ¶¼ºÀÌ ¿¡½ºÆ®·Î°Õ ¼ö¿ëü ÇÔÀ¯ ¼¼Æ÷³» À¯ÀüÀÚ ¹ßÇö¿¡ ¹ÌÄ¡´Â
¿µÇâ(cDNA microarray)...........................................22
2.5. Ç×»êÈ­Á¦¿¡ ÀÇÇÑ Áß±Ý¼Ó µ¶¼º °æ°¨¿¡ °üÇÑ ¿¬±¸...............23
2.5.1. Ç×»êÈ­Á¦¿¡ ÀÇÇÑ ¼¼Æ÷ »ýÁ¸À²(MTT assay)...................23
2.5.2. Ç×»êÈ­Á¦¿¡ ÀÇÇÑ ´Ü¹éÁú ¹ßÇö¿¡ ¹ÌÄ¡´Â ¿µÇâ................23
2.6. Åë°èºÐ¼®...................................................24
III. °á°ú.......................................................26
3.1. ¼¼Æ÷»ç¸ê°ú µ¶¼ºÈ®ÀÎ........................................26
3.2. ¿¡½ºÆ®·Î°Õ ¼ö¿ëü °æ·Î¸¦ ÅëÇÑ µ¶¼ºÀÇ »ó°ü¼º ¿©ºÎ È®ÀÎ......34
3.2.1. Á߱ݼÓÀÇ ¿¡½ºÆ®·Î°Õ Ȱ¼º ¹× µ¶¼º À¯¹ß ±Ô¸í...............34
3.2.2. Áß±Ý¼Ó µ¶¼ºÀ¯¹ßÀÌ ´Ü¹éÁú ¹ßÇö¿¡ ¹ÌÄ¡´Â ¿µÇâ..............38
3.2.3. Áß±Ý¼Ó µ¶¼ºÀÌ ¿¡½ºÆ®·Î°Õ ¼ö¿ëü ÇÔÀ¯ ¼¼Æ÷³» À¯ÀüÀÚ ¹ßÇö¿¡ ¹ÌÄ¡´Â
¿µÇâ............................................................46
3.3. Ç×»êÈ­Á¦¿¡ ÀÇÇÑ Áß±Ý¼Ó µ¶¼º °æ°¨¿¡ °üÇÑ ¿¬±¸...............56
IV. °íÂû........................................................63
Âü°í¹®Çå........................................................65
ABSTRACT........................................................73
º»¹®³»¿ë Ä«µå¹Å ¹× ºñ¼Ò´Â ´Ù¾çÇÑ ¼¼Æ÷¿Í Àå±â¿¡¼­ µ¶¼ºÀ» À¯¹ß½ÃŲ´Ù´Â ¿¬±¸º¸°í°¡ ÀÖÀ¸¸ç,
ÀÎü¿Í µ¿¹°¿¡¼­ ¸¹Àº µ¶¼º¿¬±¸°¡ ÁøÇà Áß¿¡ ÀÖ´Ù. ±×·¯³ª Ä«µå¹Å ¹× ºñ¼Ò¿¡ ´ëÇÑ
µ¶¼º±âÀü°ú ¿¡½ºÆ®·Î°Õ ¼ö¿ëü¿ÍÀÇ »ó°ü¼º¿¡ ´ëÇØ¼­´Â ¾ÆÁ÷±îÁö ¸íÈ®È÷ ¹àÇôÁöÁö ¾Ê¾Ò´Ù.
µû¶ó¼­ º» ¿¬±¸¿¡¼­´Â ¿¡½ºÆ®·Î°Õ ¼ö¿ëü¸¦ ÇÔÀ¯ÇÏ´Â ¼¼Æ÷ÀÎ MCF-7 ¼¼Æ÷¸¦ ÀÌ¿ëÇÏ¿©
Ä«µå¹Å ¹× ºñ¼Ò¿¡ ´ëÇÑ µ¶¼º¿µÇâ ¹× ¿¡½ºÆ®·Î°Õ ¼ö¿ëü¿ÍÀÇ »ó°ü¼ºÀ» Á¶»çÇϰíÀÚ ÇÏ¿´´Ù.
Ä«µå¹Å ¹× ºñ¼Ò¿¡ ´ëÇÑ ¼¼Æ÷µ¶¼º Æò°¡¸¦ À§ÇØ MCF-7 ¼¼Æ÷¿¡ ´ëÇÑ IC 50 ¼öÄ¡¸¦ Á¶»çÇÑ
°á°ú Ä«µå¹Å(55.54 ¥ìM)°ú ºñ¼Ò(123.02 ¥ìM)°£ÀÇ Â÷À̸¦ ³ªÅ¸³ÂÀ¸¸ç, DAPI ¿°»ö, DNA
fragmentation ¹× FACS ºÐ¼®À» ÅëÇØ ¼¼Æ÷»ç°¡ ³óµµ ÀÇÁ¸ÀûÀ¸·Î Áõ°¡ µÇ´Â °ÍÀ»
È®ÀÎÇÏ¿´´Ù. Ä«µå¹Å ¹× ºñ¼Ò ó¸® ½Ã ERE luciferase Ȱ¼ºÀ» ÃøÁ¤ÇÑ °á°ú Ä«µå¹ÅÀÌ 50
¥ìM ¿¡¼­ ¿¡½ºÆ®·Î°Õ Ȱ¼ºÀ» ³ªÅ¸³½ °Í¿¡ ¹ÝÇÏ¿©, ºñ¼ÒÀÇ °æ¿ì´Â Ȱ¼ºÀ» ³ªÅ¸³»Áö ¾Ê¾Ò´Ù.
Ä«µå¹Å ¹× ºñ¼Ò¿¡ ÀÇÇØ À¯µµµÈ µ¶¼ºÀ¯¹ß°ú °ü·ÃµÈ À¯ÀüÀÚ ¹ßÇö º¯È­¸¦ Á¶»çÇÑ °á°ú µÎ
°¡Áö Áß±Ý¼Ó ¸ðµÎ¿¡¼­ »êÈ­Àû ½ºÆ®·¹½º ÀÛ¿ë °ü·Ã À¯ÀüÀÚ(heme oxygenase 1,
selenoprotein, thioredoxin 2, h eat shock protein, methllothione in) ¹ßÇöÀÌ °øÅëÀûÀ¸·Î
Áõ°¡ÇÏ¿´´Ù. ºñ±³ÇÒ¸¸ÇÑ Á¡Àº ºñ¼Ò¸¦ ó¸®ÇÑ °æ¿ì¿¡´Â ¼¼Æ÷¼ºÀå ¹× ½ÅÈ£ÀüÀß °ü·Ã
À¯ÀüÀÚ(Insulin-like growth factor 1 receptor, WNT, ARNT, NF¥êB)°¡ Áõ°¡ÇÏ¿´´Ù´Â
°ÍÀÌ´Ù.
Âü°íÀÚ·á IARC. Beeyllium, cadmium, mercury and exposures in the glass ma nufacturing
industry. In Monographs on the Evaluation of the Carcinogenic R isks to Humans.
International Agency for Research on Cancer, Lyon, France, 58:1 19-237, 1993.

Johnson, M. D., Kenery, N., Stoica, A., Hilakivi-Clarke, L., Sin ȣ, B., Chepko, G.
Clarke, R., Sholler, P. F., Lirio, A. A., Foss, C., Reiter, R., Trock, B., Paik, S., Martin,

M. B. Cadmium mimics the in vivo efects of estrogen in the ute rus and mammary
gland. Nat. Med., 9(8):1081-1084, 2003.

Jung, M. C., Thornton, I. Environmental contamination and seaso nal variation of
metals in soils plants and waters in the pady around a Pb-Zn m ine in Korea. Sci.
Total Environ., 198:105-121, 1997.

Kim, S. Cho, M. K., Kim, S. G. Cadmium-induced non-apoptotic ce ll death mediated
by oxidative stress under the condition of sulfhydryl deficienc y. Toxicol. Lett.,
144(3):325-336, 2003.

Klassen, C.D., Amdur, M.O. and Doull, J. CaSarett and Doull`s Toxicology. Macmillan
Publishing Company, New York, 592-596, 1998.

Koizumi, S., Yamada, H. DNa microarray analysis of altered gene expresion in
cadmium-exposed human cells. J. Occup. Health, 45(6):331-334, 2 003.

Kond, M.L., Zhao, Q., Li, F.J., Tanabe, K., Arai, Y., Zhou, Z.C., and Kasuya, M.
Apoptosis induced by cadmium in human lumphoma U937 cells throu gh Ca2+-
calpain and caspase - mitochondria-dependent pathways. The Jour nal of Biological
Chemistry. The Journal of Biological Chemistry, 275:39702-39709 , 2000.

Lander, H. M. An essential role for free radicals and derived s pecies in signal
transduction. FASEB J., 11(2):118-124, 1997.

Lee Jeing Ho, You II Soo, Lee Ki Nam, Ji Jeong Ok, Han Du Seok, Shin Min Kyo, II
Jeong Seung, Oh Hyun Ju and Baek Seung Hwa. The protective Efe cts of the
Extract of Saururus chinesis Against Cadmium Induced Cytotoxici ty(II). J. Tocicol,
Pub. Health vol. 17(3):173-180, 2001.

Manca, D., Ricard, A. C., Trottier, B., Chevalier, G. Studies on lipid peroxidation in
rat tissues following administration of low and moderate doses of cadmium chloride.
Toxicology, 67(3):303-323, 1991.

Misra, M. D., Freedman, J. H. Protective effects of aspirin and vitamin E (alpha-
tocopherol) against coper- and cadmium-induced toxicity. Bioch em. Biophys. Res.
Commun., 285(4):921-295, 2002.

Muller, L. Consequences of cadmium toxicity in rat hepatocyres: mitochondrial
dysfunction and lipid peroxidation. Toxicology, 40(3):285-295, 1986.

Ochi, T., Takahashi, K., Ohsawa, M. Indirect evidence for the i nduction of a
prooxidant state by cadmium chloride in cultured mammalian cell s and a possible
mechanism for the induction. Mutat. Res., 180(2):257-266, 1987.

Patrick, L. Toxic metals and antioxidants: Part II. The role of antioxidants in
arsenic and cadmium toxicity. Altern. Med. Rev., 8(2):106-128, 2003.

Regunathan, A., Glesne, D. A., Wilson, A. K., Song, J., Nicolae, D., Flores, T.,
Bhattacharyya, M. H. Microarray analysis of changes in bone cel l gene expression
early after cadmium gavage in mice. Toxicol. Appl. Pharmacol, 191(3):272-293,
2003.
Çб³Á¤º¸ 2ÁÖ°£ ´Ù¿î¹ÞÀº ÇлýÀÇ Çб³Á¤º¸¸¦ º¸¿©ÁÝ´Ï´Ù.(5P ¼Ò¿ä)
ÀúÀÛ±Ç Á¤º¸ À§ Á¤º¸ ¹× °Ô½Ã¹° ³»¿ëÀÇ Áø½Ç¼º¿¡ ´ëÇÏ¿© ÇØÇÇÄ·ÆÛ½º´Â º¸ÁõÇÏÁö ¾Æ´ÏÇϸç, ÇØ´ç Á¤º¸ ¹× °Ô½Ã¹° ÀúÀ۱ǰú ±âŸ ¹ýÀû Ã¥ÀÓÀº ÀÚ·á µî·ÏÀÚ¿¡°Ô ÀÖ½À´Ï´Ù.
À§ Á¤º¸ ¹× °Ô½Ã¹° ³»¿ëÀÇ ºÒ¹ýÀû ÀÌ¿ë, ¹«´Ü ÀüÀ硤¹èÆ÷´Â ±ÝÁöµÇ¾î ÀÖ½À´Ï´Ù.ÀúÀÛ±ÇÄ§ÇØ, ¸í¿¹ÈÑ¼Õ µî ºÐÀï¿ä¼Ò ¹ß°ß½Ã °í°´¼¾ÅÍÀÇ ÀúÀÛ±ÇÄ§ÇØ ½Å°í¼¾Å͸¦ ÀÌ¿ëÇØ Áֽñ⠹ٶø´Ï´Ù.

±¸¸ÅÆò°¡(
0
)
±¸¸Å¹®ÀÇ(
0
)
Æ®·¢¹é(
0
)